Health Condition 1: D509- Iron deficiency anemia, unspecified
Conditions
Interventions
Intervention1: Individualized Homoeopathic Medicine: 1)Selection of cases for the study fulfill the
inclusion criteria,Obtain Informed Consent
and diagnosed cases of IDA
2)Case Taking, Case Analysis
Sponsors
Dr. Kinjal Gajanan Patil
Eligibility
Inclusion criteria
Inclusion criteria: Women aged between 18 to 49 years (reproductive age group). Diagnosed cases of Iron Deficiency Anemia with hemoglobin levels less than 12 grams per decilitre. Willing to undergo homoeopathic treatment and provide informed consent. Patients showing symptoms such as fatigue, pallor, weakness, dizziness, or shortness of breath. Residents of study location. Patients from different occupation and socioeconomic status. Patients diagnosed with mild to moderate grade anaemia (haemoglobin levels between 8 grams per decilitre and the lower limit of normal, as per NIH guidelines, 2011) will be considered for the study.
Exclusion criteria
Exclusion criteria: Womens of age below 18yrs and above 49yrs. Women with anemia due to causes other than iron deficiency (e.g., hemolytic anemia,thalassemia, chronic kidney disease). Pregnant or lactating women. Patients on conventional iron supplements or allopathic treatment during the study period. Women with systemic illnesses such as tuberculosis, cancer, or HIV. Patients with accidental injuries resulting in severe blood loss. Patients with known hemorrhagic disorders or bleeding tendencies. Womens having Any systemic or Hormonal diseases. Patients with severe anaemia (haemoglobin level less than 8 grams per decilitre). Individuals unwilling to participate or unable to comply with follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Hematological outcome (Objective assessment): Based on pre- and post-treatment hemoglobin levels. 2) Change in FACIT-Fatigue score from Baseline to end of treatment to evaluate symptomatic improvement.Timepoint: Duration of study is 18 months. Each case will be studied for a period of 6 months or until remission occurs, whichever is earlier. Each case will be followed up at intervals of 15 to 30 days or as and when required. Clinical assessment will be carried out at baseline and at the completion of 6 months, Whichever is earlier. | — |
Secondary
| Measure | Time frame |
|---|---|
| General Well-being Indicators(Qualitative Assessment): a. Improved energy and appetite b. Regularized menstruation (if previously irregular) c. Improved mood and sleep d. Observations by the patient and physician during follow-upTimepoint: General well being will be assessed qualitatively at each followup visit and final assessment will be done at the end of the study | — |
Countries
India
Contacts
Public ContactDr Rashmi Desarda
Guru Mishri Homoeopathic Medical College and Hospital, Shelgaon, Jalna
Outcome results
None listed